Interviews

Lipid accumulation product had high potential in predicting the risk of gout/hyperuricemia in new research, offering a potentially modifiable risk factor for preventing gout.1 “Traditional metrics for evaluating obesity, such as Body Mass Index (BMI) and Waist Circumference (WC), have been widely utilized; however, they exhibit significant limitations in accurately reflecting the complex nature of … Read more

Image Credit: Adobe Stock A recent study from Sapienza University of Rome has indicated that optical coherence tomography (OCT) features such as type 2 macular neovascularization (MNV), reductions in outer nuclear layer (ONL) and central foveal thickness (CFT), and intraretinal fluid (IRF) presence at baseline could signal higher risks of retinal atrophy (RA) in treatment-naïve … Read more

Actinic keratosis represents one of modern healthcare’s most overlooked and dangerous skin conditions. With global prevalence estimates of 14% and higher rates observed in older populations and those with significant UV exposure, the precancerous condition poses a significant risk to long-term health when left untreated or undiagnosed.1 “It’s really important that not just dermatologists, but … Read more

A recent retrospective study from Zhejiang, China has indicated that triamcinolone acetonide (TA) injections may successfully prevent the onset of diabetic macular edema (DME) after pars plana vitrectomy (PPV), a common postoperative complication in patients with proliferative diabetic retinopathy (PDR).1 Macular edema is a very common complication with many ocular diseases; it manifests as accumulation … Read more

Semaglutide demonstrated notable protective effects on osteoporosis and gout in people with obesity and type 2 diabetes (T2D) in a new cohort study.1 “The impact of newer anti-obesity medications on skeletal health remains incompletely understood, particularly in populations with varying metabolic profiles,” lead investigator Jo-Ching Chen, Chung Shan Medical University Hospital, Taichung, Taiwan, and colleagues … Read more

Ioannis Parodis, MD, PhD Credit: Research Gate A new meta-analysis has found that belimumab was superior to placebo according to BICLA criteria in patients with systemic lupus erythematosus (SLE).1 “The results from this post hoc analysis of foundational phase III SLE belimumab trials have important implications for clinical practice, as they substantiate the clinical efficacy … Read more